This case study showcases the successful expansion of mesenchymal stem cells [MSCs] using Rooster Bio's xeno-free MSC platform in Univercells Technologies' scale-X fixed-bed bioreactor. The collaboration highlights seamless process transfer, rapid cell attachment, optimized harvesting with high viability [96%], and robust scalability from R&D to GMP manufacturing. Key innovations include predictive bioprocess monitoring with Scalia Vision and cost-effective solutions for advanced therapy manufacturing.